Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.74 HKD | -1.58% | +7.34% | -53.58% |
Business Summary
Number of employees: 12,740
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologics
88.8
%
| 2,582 | 14.5 % | 16,717 | 88.8 % | +547.32% |
XDC
11.2
%
| - | - | 2,106 | 11.2 % | - |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
47.4
%
| 9,880 | 55.6 % | 8,921 | 47.4 % | -9.71% |
Europe
30.2
%
| 2,961 | 16.7 % | 5,681 | 30.2 % | +91.85% |
China
18.3
%
| 4,325 | 24.4 % | 3,449 | 18.3 % | -20.24% |
Rest of the World
4.1
%
| 590 | 3.3 % | 772 | 4.1 % | +30.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 11-05-31 |
Ming Tu
DFI | Director of Finance/CFO | 54 | 21-08-22 |
Gu Jijie
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Weichang Zhou
BRD | Director/Board Member | 59 | 12-11-30 |
Yue Huang
SEC | Corporate Secretary | - | 18-11-19 |
Ying Man Sham
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jackson Tai
BRD | Director/Board Member | 73 | 23-05-05 |
William Keller
BRD | Director/Board Member | 75 | 17-05-16 |
Ge Li
CHM | Chairman | 56 | 10-04-30 |
Yan Ling Cao
BRD | Director/Board Member | 39 | 16-04-30 |
Yi Bing Wu
BRD | Director/Board Member | 55 | 16-04-30 |
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 11-05-31 |
Weichang Zhou
BRD | Director/Board Member | 59 | 12-11-30 |
Kenneth Hitchner
BRD | Director/Board Member | 63 | 20-06-08 |
Jue Chen
BRD | Director/Board Member | 54 | 23-08-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,259,278,169 | 3,655,310,975 ( 85.82 %) | 0 | 85.82 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
WuXi Biologics (Hong Kong) Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.58% | 7.42B | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.89% | 22.18B | |
-16.67% | 21.2B | |
-9.33% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- 2269 Stock
- Company WuXi Biologics (Cayman) Inc.